Scope of the Study
Heatstroke is the most serious form of heat injury and is considered a medical emergency. It can kill or cause damage to the brain and other internal organs. It often occurs as a progression from milder heat-related illnesses such as heat cramps, heat syncope (fainting), and heat exhaustion. The main aim of the heatstroke treatment is to lower the patientís temperature and prevent further damage. The medications used in the treatment involves antihistamines, diet pills, diuretics, sedatives, tranquilizers, stimulants, seizure medications (anticonvulsants), heart and blood pressure medications such as beta-blockers and vasoconstrictors, and medications for psychiatric illnesses such as antidepressants and antipsychotics.
The market study is being classified by Type (Exertional Heat Stroke and Non-Exertional Heat Stroke) and major geographies with country level break-up.
Mankind Pharma (India), Eagle Pharmaceuticals, Inc. (United States), Otsuka Pharmaceutical Co., Ltd. (Japan), Medisim (United States), Takeda Pharmaceutical Company Limited (Japan), Novartis International AG (Switzerland), Daiichi Sankyo Company, Limited (Japan), Johnson & Johnson Services, Inc (United States), Abbott (United States) and AstraZeneca (United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are ALLERGAN (Ireland) and Sun Pharmaceutical Industries Ltd (India).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Heatstroke Treatment market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Heatstroke Treatment market by Type, Application and Region.
On the basis of geography, the market of Heatstroke Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Heatstroke among People
- Rising Number of Hospitals and Diagnostic Centres
- Increased Number of Online Pharmacies
- Rise in the Research and Development Activities
- Side Effects of the Medications used for Treatment
- Growth in the Healthcare Industry Worldwide
- Increased Healthcare Infrastructure in Developing Countries
- Stringent Government Rules and Regulations
Key Target AudienceHeatstroke Treatment Providers, Research Professionals, Emerging Companies and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase